Cnbc Marcus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Is there freedom of speech when you work for a big company not. Well debate the profits go to pot quite literally. Cnbcs marcus limonus goes inside californias market he is going to give us a sneak peek power lunch starts right now welcome, everybody, to power lunch. Im Tyler Mathisen i am never disappointed when jeff done lunlop is on fasfas one more time, the dow is at record, 22,135 on the verge of an 11day win streak and potentially its tenth Straight Record close. The s p 500 joining the party. Record interday high there up three points or. 14 check out some movers. Fibrogen, up 50 and on...

Offering, yielding the 8 range. Thats juicy, tempting. But we start with Sheila Dharmarajan and a very controversial new drug, oxycodone very prone to abuse. This is a more potent variant. Yes, it is super potent. Its also super controversial. I want to talk a little about the drug because its important here. It is a painkiller marketed by a small company. The active ingredient is hydrocodo hydrocodone, the same stuff you find in vicodin but unlike vicodin, this is pure hydrocodone in a higher dosage form. Thats actually the positives of the drug because it makes it very effective for chronic ...

Down about 48 points, 15,470. The industrial average settles out, look at the volume number on the light side. 540 million shares traded. The nasdaq gave up 11. 75, 3,654. And the s p 500 tonight down 6. 50 at 1,690. By the way, all of the major averages finishing off the lows of the day. Even though were down in the double digits, we had buyers throughout the session today. It was nonetheless, though, a downer for the broad market. Bob pisani, put things in perspective for us today on the heels of what has been a record setter for this market. Reporter the big story is the constant commentary...